Exophytic ulcerated tumors in HIV patients: Diagnostic and therapeutic problems

Dermatology

Volumn 216, Issue 1, 2007, Pages 60-63

  Lautenschlager, Stephan ^a   Schwarzkopf, Stefan ^a   Keller, Beat ^b  

^a TRIEMLI HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Genital herpes; Herpes simplex virus; HIV; Sexually transmitted infection

Indexed keywords

ACICLOVIR; EFAVIRENZ; FOSCARNET; IMIQUIMOD; LAMIVUDINE; PENICILLIN V; VALACICLOVIR; ZIDOVUDINE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CELL INFILTRATION; CLINICAL FEATURE; DRUG TREATMENT FAILURE; EPITHELIUM TUMOR; GENITAL HERPES; GENITAL ULCER; HERPES SIMPLEX VIRUS 2; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; MALE HOMOSEXUAL; PENIS TUMOR; PHENOTYPE; PRIORITY JOURNAL; SKIN TUMOR; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; DIAGNOSIS, DIFFERENTIAL; GENITAL NEOPLASMS, MALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV; HUMANS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 36348937897     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109360     Document Type: Article

References (32)

1. Czelusta A, Yen-Moore A, Van der Straten M, Carrasco D, Tyring SK: An overview of sexually transmitted diseases. III. Sexually transmitted diseases in HIV-infected patients. J Am Acad Dermatol 2000;43:409-432.
2. Strick LB, Wald A, Celum C: Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Clin Infect Dis 2006;43:347-356.
3. Siegal FP, Lopez C, Hammer GS, Brown AE, Kornfeld SJ, Gold J, et al: Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981;305:1439-1444.
4. Penneys NS, Hicks B: Unusual cutaneous lesions associated with acquired immunodeficiency syndrome. J Am Acad Dermatol 1985;13:845-852.
5. Tong P, Mutasim DF: Herpes simplex virus infection masquerading as condyloma acuminata in a patient with HIV disease. Br J Dermatol 1996;134:797-800.
6. Skinhoj P: Herpesvirus infections in the immunocompromised patient. Scand J Infect Dis Suppl 1985;47:121-127.
7. Tyring SK, Carlton SS, Evans T: Herpes: atypical clinical manifestations. Dermatol Clin 1998;16:783-788.
8. Maier JA, Bergman A, Ross MG: Acquired immunodeficiency syndrome manifested by chronic primary genital herpes. Am J Obstet Gynecol 1986;155:756-758.
9. Vogel P, Smith KJ, Skeleton HG, Cuozzo D, Wagner KF: Verrucous lesions of herpes simplex in HIV-1+ patients. Military Medical Consortium for the Advancement of Retroviral Research. Int J Dermatol 1993;32:680-682.
10. Carrasco DA, Trizna Z, Colome-Grimmer M, Tyring SK: Verrucous herpes of the scrotum in a human immunodeficiency virus-positive man: case report and review of the literature. J Eur Acad Dermatol Venereol 2002;16:511-515.
11. Stewart JA, Reef SE, Pellett PE, Corey L, Whitley RJ: Herpesvirus infections in persons infected with human immunodeficiency virus. Clin Infect Dis 1995;21(suppl 1):S114-S120.
12. Rosen T, Brown TJ: Genital ulcers: evaluation and treatment. Dermatol Clin 1998;16:673-685.
13. Al Rajabi W, Venturini M, Sala R, Calzavara-Pinton P: Wegener's granulomatosis of the penis: genital presentation of systemic disease. Dermatology 2006;212:370-372.
14. Alpsoy E, Elpek GO, Yilmaz F, Ciftcioglu MA, Akman A, Uzun S, et al: Androgen receptor levels of oral and genital ulcers and skin pathergy test in patients with Behcet's disease. Dermatology 2005;210:31-35.
15. Samaratunga H, Weedon D, Musgrave N, McCallum N: Atypical presentation of herpes simplex (chronic hypertrophic herpes) in a patient with HIV infection. Pathology 2001;33:532-535.
16. Lanzafame M, Mazzi R, Di Pace C, Trevenzoli M, Concia E, Vento S: Unusual, rapidly growing ulcerative genital mass due to herpes simplex virus in a human immunodeficiency virus-infected woman. Br J Dermatol 2003;149:216-217.
17. Dehen L, Vilmer C: Herpes génital de présentation tumorale chez une patiente infectée par le VIH. Ann Dermatol Venereol 2006;133:393-394.
18. Husak R, Tebbe B, Goerdt S, Wolfer LU, Zeichardt H, Stoffler-Meilicke M, et al: Pseudotumour of the tongue caused by herpes simplex virus type 2 in an HIV-1 infected immunosuppressed patient. Br J Dermatol 1998;139:118-121.
19. Fox PA, Barton SE, Francis N, Youle M, Henderson DC, Pillay D, et al: Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease. HIV Med 1999;1:10-18.
20. French MA, Price P, Stone SF: Immune restoration disease after antiretroviral therapy. AIDS 2004;18:1615-1627.
21. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ: Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006;42:418-427.
22. Lehloenya R, Meintjes G: Dermatologic manifestations of the immune reconstitution inflammatory syndrome. Dermatol Clin 2006;24:549vii-570vii.
23. Reyes M, Shaik NS, Graber JM, Nisenbaum R, Wetherall NT, Fukuda K, et al: Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med 2003;163:76-80.
24. Danve-Szatanek C, Aymard M, Thouvenot D, Morfin F, Agius G, Bertin I, et al: Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol 2004;42:242-249.
25. Bratzke B, Orfanos CE, Stavermann T, Ehlers G: Chronisch-erosiver, therapierefraktärer perianaler Herpes (Typ II) mit Herpes Proktitis bei AIDS. Hautarzt 1991;42:96-100.
26. Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 2006;55:1-93.
27. Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, et al; AIDS Clinical Trials Group: A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med 1991;325:551-555.
28. Danielsen AG, Petersen CS, Iversen J: Chronic erosive herpes simplex virus infection of the penis in a human immunodeficiency virus-positive man, treated with imiquimod and famciclovir. Br J Dermatol 2002;147:1034-1036.
29. Saint-Léger E, Fillet AM, Malvy D, Rabanel B, Caumes E: Efficacitédu cidofovir dans un herpès cutanéré sistant àl'aciclovir et au foscarnet chez un malade séropositif pour le VIH. Ann Dermatol Venereol 2001;128:747-749.
30. Janier M, Scieux C, Meouchi R, Tournoux C, Porcher R, Maillard A, et al: Virological, serological and epidemiological study of 255 consecutive cases of genital herpes in a sexually transmitted disease clinic of Paris (France): a prospective study. Int J STD AIDS 2006;17:44-49.
31. Sacks SL, Shafran SD, Diaz-Mitoma F, Trottier S, Sibbald RG, Hughes A, et al: A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes. Antimicrob Agents Chemother 1998;42:2996-2999.
32. Pechère M, Wunderli W, Trellu-Toutous L, Harms M, Saurat JH, Krischer J: Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis. Dermatology 1998;197:278-280.